Extended Data Fig. 5: OncoKB clinical actionability across the three genomic subtypes of PDAC.
Prevalence of actionable alterations by OncoKB levels of actionability across KRASMUT, other-MAPKMUT and MAPKWT tumors.
Extended Data Fig. 5: OncoKB clinical actionability across the three genomic subtypes of PDAC. | Nature Medicine
